Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Apr 1;30(9):1634–1642. doi: 10.1158/1055-9965.EPI-20-1633

Table 3.

Associations of metabolites and gastric cancer risk: backward selection and mutual adjustment

Metabolites OR (95%CI) P
methylmalonate (MMA) 1.31 (0.91–1.87) 0.0017
N-(2-furoyl) glycine 0.75 (0.55–1.03) 0.0022
orotate 1.34 (1.03–1.75) 0.0043
cysteine 1.48 (1.05–2.09) 0.0072
1-(1-enyl-oleoyl)-2-docosahexaenoyl-GPE (P-18:1/22:6) 1.40 (1.05–1.86) 0.0171
5alpha-pregnan-diol disulfate 1.43 (1.07–1.91) 0.0221
1-stearoyl-GPC (18:0) 0.66 (0.49–0.90) 0.0253
N6-methyllysine 1.62 (1.16–2.25) 0.0301
quinate 0.58 (0.41–0.82) 0.0794
glycerophosphoethanolamine 1.73 (1.23–2.42) 0.1456

The covariates listed in Table 2 were included in the regression analysis.